Minerva Neurosciences, Inc.
NERV
$4.74
$0.112.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 5.26M | 5.76M | -- | 1.30M | 1.36M |
| Gross Profit | -5.26M | -5.76M | -- | -1.30M | -1.36M |
| SG&A Expenses | 11.42M | 2.81M | 1.92M | 2.08M | 2.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.67M | 4.98M | 2.84M | 3.37M | 3.90M |
| Operating Income | -16.67M | -4.98M | -2.84M | -3.37M | -3.90M |
| Income Before Tax | -125.40M | -283.67M | -2.74M | -3.26M | -3.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -125.40M | -283.67M | -2.74M | -3.26M | -3.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.40M | -283.67M | -2.74M | -3.26M | -3.75M |
| EBIT | -16.67M | -4.98M | -2.84M | -3.37M | -3.90M |
| EBITDA | -16.67M | -4.98M | -2.84M | -3.37M | -3.90M |
| EPS Basic | -2.86 | -25.51 | -0.36 | -0.43 | -0.50 |
| Normalized Basic EPS | -1.79 | -15.95 | -0.23 | -0.27 | -0.31 |
| EPS Diluted | -2.86 | -25.51 | -0.36 | -0.43 | -0.50 |
| Normalized Diluted EPS | -1.79 | -15.95 | -0.23 | -0.27 | -0.31 |
| Average Basic Shares Outstanding | 43.90M | 11.12M | 7.57M | 7.57M | 7.57M |
| Average Diluted Shares Outstanding | 43.90M | 11.12M | 7.57M | 7.57M | 7.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |